Arete Wealth Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-32,616
| Closed | -$58K | – | 785 |
|
|
2024
Q4 | $58K | Sell |
32,616
-33,556
| -51% | -$59.7K | ﹤0.01% | 729 |
|
|
2024
Q3 | $114K | Sell |
66,172
-16,748
| -20% | -$28.9K | 0.01% | 671 |
|
|
2024
Q2 | $110K | Buy |
82,920
+26,052
| +46% | +$34.6K | 0.01% | 687 |
|
|
2024
Q1 | $213K | Buy |
56,868
+39,757
| +232% | +$149K | 0.02% | 373 |
|
|
2023
Q4 | $168K | Buy |
17,111
+4,664
| +37% | +$45.8K | 0.01% | 689 |
|
|
2023
Q3 | $104K | Sell |
12,447
-419
| -3% | -$3.5K | 0.02% | 467 |
|
|
2023
Q2 | $171K | Sell |
12,866
-834
| -6% | -$11.1K | 0.02% | 608 |
|
|
2023
Q1 | $159K | Buy |
+13,700
| New | +$159K | 0.01% | 588 |
|
|
2022
Q4 | – | Sell |
-15,042
| Closed | -$87K | – | 687 |
|
|
2022
Q3 | $87K | Buy |
15,042
+1,366
| +10% | +$7.9K | 0.01% | 542 |
|
|
2022
Q2 | $60K | Buy |
+13,676
| New | +$60K | 0.01% | 445 |
|